Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn

Company News Summary

Sigma Pharmaceuticals Provides Trading Update

17 Feb 2017  |  09:28:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Trading Update

Sigma Pharmaceuticals announced its results for the full year ended 31 January 2017. It advises that underlying EBIT is expected to be just over $100m, which is 12% above last year. This compares to previous guidance of 10% underlying EBIT growth, and remains subject to audit and Board signoff. Reported EBIT is however expected to be broadly in line with last year, impacted by one-off accounting adjustments totalling almost $20m. This reflects the insurance premium recovery of $11.4m announced on 13 May 2016, and an additional provision for doubtful debt relating to a single pharmacy group.

Please click here for full details

See more ASX300 News Announcements